Evidence map›Paper›PMID 41961719›Full record

ReviewMedicine2026

Primary leiomyosarcoma originating from the deep femoral vein initially presenting as chronic deep vein thrombosis: A case report and review of literature.

Eunju Jang, Ki Yoon Moon, Sun Cheol Park, Jang Yong Kim, Sang Seob Yun

Abstract readCase ReportsReview
In one paragraph

Review in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eunju JangDivision of Vascular and Transplant Surgery, Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.ORCID 0000-0002-6155-7318
Sang Seob Yun

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leiomyosarcoma (LMS) is a rare and aggressive smooth muscle tumor, and venous leiomyosarcoma (VLMS) is an uncommon subtype, with majority of the cases involving the vena cava. We report a case of a 56-year-old patient initially diagnosed as deep vein thrombosis (DVT) in the common femoral vein who was later diagnosed with primary VLMS originating from the deep femoral vein. Despite anticoagulation therapy, leg edema persisted and imaging studies revealed an intraluminal mass with increased extent and size. Initial duplex ultrasound suggested chronic DVT; however subsequent contrast-enhanced computed tomography and magnetic resonance imaging performed during follow-up demonstrated interval growth of an intraluminal mass, and positron emission tomography-computed tomography later confirmed metabolically active disease, leading to the diagnosis of VLMS. Surgical resection of the mass was performed, followed by reconstruction of the femoral vein using an expanded polytetrafluoroethylene graft. Histopathologic examination confirmed the diagnosis of LMS. The patient had an uneventful postoperative recovery and was referred for adjuvant therapy, including chemotherapy and radiotherapy. This case highlights the importance of a multimodal diagnostic approach in differentiating neoplasms from blood clots and underscores the need for a high level of suspicion when DVT presents with atypical features. Early diagnosis and wide surgical excision with the aim of achieving negative margins are essential for successful management of VLMS.

Indexed as

Femoral VeinLeiomyosarcomaVascular NeoplasmsVenous ThrombosisDiagnosis, DifferentialHumansMagnetic Resonance ImagingMaleMiddle AgedTomography, X-Ray Computedbypassfemoral veinleiomyosarcomavascular surgery

Identifiers

PMID41961719
PMCPMC13593078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.